facilitate regeneration in seriously damaged spinal cords. She has served on National Institutes of Health study sections and the National Advisory Neurological Disorders and Stroke Council. She received the Wakeman Award (1996) for her seminal contributions to the field of spinal cord injury repair, the Christopher Reeve Research Medal for Spinal Cord Repair (2001), and the Javits Neuroscience Investigator Award (1998) and was the first recipient of the Mika Salpeter Women in Neuroscience Life-time Achievement Award (2000). From 1996 to 1997 she served as interim scientific director of the Miami Project to Cure Paralysis. She is a member of the research consortium of the Christopher Reeve Paralysis Foundation and the Dana Alliance for Brain Initiatives.
Fred H. Gage, Ph.D., is the Vi and John Adler Professor of the Laboratory of Genetics at the Salk Institute in San Diego, California. Dr. Gage’s research focuses on the structural plasticity in the adult nervous system. In addition to studying the mechanism and function of adult neurogenesis, his research efforts also focus on genetic engineering and cell transplantation strategies to reverse or restore function lost as a result of neurodegeneration or neurotrauma. In 1998 he led the team that discovered neural stem cells in the human brain. His professional activities have included service on the National Institutes of Health (NIH) Advisory Council on Aging, the NIH Working Group on Guidelines for the Use of Human Embryonic Stem Cells, the Research Consortium of the Christopher Reeve Paralysis Foundation, and the Advisory Board of the American Society of Gene Therapy. Dr. Gage has also served on the editorial boards of more than two dozen scientific journals and as president of the Society for Neuroscience. He has received numerous awards and honors, including the NIH Merit Award, and the Decade of the Brain Medal. He was elected to the Institute of Medicine (IOM) in 2001 and the National Academy of Sciences in 2003 and served on an IOM committee that studied the biological impact of exposure to electromagnetic fields (1996).
Suzanne T. Ildstad, M.D., is director of the Institute for Cellular Therapeutics (ICT), the Jewish Hospital Distinguished Professor of Transplantation, and professor of surgery at the University of Louisville. ICT is a multi-disciplinary translational research program designed to develop cellular therapies and rapidly transfer them from the laboratory to the clinic. Dr. Ildstad’s research focuses on developing methods to make bone marrow transplantation safe enough for widespread application for the treatment of autoimmune diseases, the induction of tolerance to organ and islet cell transplants, and the treatment of hemoglobinopathies such as sickle cell disease and thalassemia. She is credited with being the first to discover “facilitator cells,” which are bone marrow cells that enhance engraftment